Kadmon Holdings Inc (KDMN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Harlan W. Waksal
Employees:
116
450 EAST 29TH STREET, NEW YORK, NY 10016
212-308-6000

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Kadmon Holdings, Inc. is a biopharmaceutical company, which discovers, develops, and commercializes small molecules and biologics. It develops product candidates in a number of indications within autoimmune and fibrotic disease, oncology, and genetic disease. It offers ribavirin tablets and capsules, phentermine and topiramate extended-release capsules, and tetrabenazine tablets. The company was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY.

Data derived from most recent annual or quarterly report
Market Cap 1.637 Billion Shares Outstanding172.35 Million Avg 30-day Volume 10.41 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.2
Price to Revenue0.0 Debt to Equity6.9607 EBITDA-109.91 Million
Price to Book Value0.0 Operating Margin-5129.355799999999 Enterprise Value659.834 Million
Current Ratio9.458 EPS Growth0.29 Quick Ratio9.33
1 Yr BETA 0.5051 52-week High/Low 9.5 / 3.2 Profit Margin-4807.0471
Operating Cash Flow Growth-39.2523 Altman Z-Score-1.0418 Free Cash Flow to Firm -84.045 Million
View SEC Filings from KDMN instead.

View recent insider trading info

Funds Holding KDMN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KDMN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KIRSCH ARTHUR S

  • Director
0 2021-11-09 3

KONIDARIS TASOS

  • Director
0 2021-11-09 2

COHEN DAVID E

  • Director
0 2021-11-09 2

WAKSAL HARLAN PRESIDENT, CEO

  • Officer
  • Director
0 2021-11-09 3

BAUER EUGENE

  • Director
0 2021-11-09 2

RYAN JOHN L EVP, CHIEF MEDICAL OFFICER

  • Officer
0 2021-11-09 1

MEEHAN STEVEN EVP, CHIEF FINANCIAL OFFICER

  • Officer
0 2021-11-09 1

MILLER-RICH NANCY

  • Director
0 2021-11-09 2

MOSS GREGORY S. EVP, GEN. COUN. / CCO.

  • Officer
0 2021-11-09 1

CARVER KYLE SVP, CAO, CONTROLLER

  • Officer
0 2021-11-09 1

FLOWERS CYNTHIA LOUISE

  • Director
0 2021-11-08 2

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
  • FORMER 10% OWNER
No longer subject to file 2019-11-18 0

GORDON STEVEN N. EXEC VP, GC, CHIEF ADMIN, COMP

0 2019-06-14 0

BOARDMAN D. DIXON

0 2019-05-15 0

VIVO CAPITAL VIII, LLC

VIVO CAPITAL FUND VIII, L.P.

VIVO CAPITAL SURPLUS FUND VIII, L.P.

VIVO OPPORTUNITY, LLC

VIVO OPPORTUNITY FUND, L.P.

  • 10% Owner
12,606,605 2019-01-07 0

SCHWARTZ BART M

0 2018-07-27 0

WIVIOTT SUSAN

0 2018-07-27 0

POUKALOV KONSTANTIN EXECUTIVE VICE PRESIDENT, CFO

0 2017-12-08 0

DARDER CHARLES PRINCIPLE ACCOUNTING OFFICER

0 2017-12-08 0

GOLDENTREE ASSET MANAGEMENT LP

GOLDENTREE ASSET MANAGEMENT LLC

TANANBAUM STEVEN A.

  • 10% Owner
17,344,959 2017-08-08 0

SHENK THOMAS E

0 2017-06-29 0

FORBES ALEXANDRIA

0 2017-06-29 0

LOEB DANIEL S

THIRD POINT LLC

  • 10% Owner
10,002,983 2017-03-13 0

EDELMAN JOSEPH

  • 10% Owner
4,955,474 2017-03-13 0

KADMON I, LLC

0 2017-01-23 0

COHEN LAWRENCE KENNETH EXEC. VP, BUSINESS DEVELOP.

0 2016-12-15 0

ZAN SHENGDA

0 2016-12-15 0

COHEN ANDREW B

0 2016-12-15 0

WITTE LARRY EXEC. VP, RESEARCH & DEVELOP.

  • Officer
30,770 2016-07-26 0

GOLDENTREE ASSET MANAGEMENT LP

GOLDENTREE ASSET MANAGEMENT LLC

TANANBAUM STEVEN A.

GAFFNEY TREACY

  • 10% Owner
1,274,127 2016-07-26 0

COHEN ANDREW

  • Director
1,058,221 2016-07-26 0

ZHU ZHENPING EXECUTIVE VP BIOLOGICS

  • Officer
18,462 2016-07-26 0

HEYMAN EVA EXEC VP, CHIEF COMMERCIAL OFFI

  • Officer
0 2016-07-26 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
KADMON HOLDINGS INC KDMN 2021-11-09 22:15:03 UTC -0.1903 0.2603 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 21:45:03 UTC -0.1903 0.2603 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 21:15:03 UTC -0.1903 0.2603 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 20:45:04 UTC -0.197 0.267 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 20:15:03 UTC -0.197 0.267 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 19:45:03 UTC -0.197 0.267 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 19:15:03 UTC -0.197 0.267 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 18:45:03 UTC -0.2166 0.2866 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 18:15:03 UTC -0.2166 0.2866 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 17:45:02 UTC -0.2166 0.2866 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 17:15:03 UTC -0.2166 0.2866 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 16:45:03 UTC -0.2166 0.2866 1100000
KADMON HOLDINGS INC KDMN 2021-11-09 16:15:04 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 15:45:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 15:15:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 14:45:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 14:15:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 13:45:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 13:15:03 UTC -0.2166 0.2866 1200000
KADMON HOLDINGS INC KDMN 2021-11-09 12:45:03 UTC -0.2166 0.2866 1200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund KDMN -93753.0 shares, $-513766.44 2021-08-31 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND KDMN -424000.0 shares, $-3693040.0 2021-09-30 N-PORT

Elevate your investments